Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

Leqselvi, part of Sun’s dermatology portfolio, was previously blocked from launch by a court order in November 2024.

According to Emkay Global, the temporary halt in US tariffs is a significant positive development. The brokerage believes ...

Analysts predict Nifty may surpass 23,000, influenced by US President Trump's announcements and RBI's rate cut.

The brokerage firm has initiated coverage on the Indian air conditioner (AC) space, with ‘BUY’ on both, Voltas and Blue Star.

Emkay Global Research has a target price of Rs 300, which implied that Fino Payments Bank stock may see an upside of 34.35% ...

Emkay Global Financial is bullish on Delhivery has recommended buy rating on the stock with a target price of Rs 400 in its ...

The likelihood of the RBI going in for another 50bps points rate cut for the rest of the calendar year is very high, says Dr ...

Emkay Global Financial is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of ...

Emkay Global warns that the Nifty could fall to 21,500 in the next three months amid escalating U.S. recession fears and ...

Emkay analysts believe a possible US recession from tariffs could reduce Nifty's FY26 earnings by 3 per cent, potentially ...